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V. Infections 
INFECTIONS AND INFESTATIONS OF THE SKIN 
Space limitations dictated that this section be selective rather 
than exhaustive. Many, if not most, infectious agents have 
manifestations in the integument. This section discusses the 
problems that are most common, most troublesome, or most 
draining of manpower or financial resources. 
Some very interesting and important skin infections such as 
unusual and deep mycoses, and diphtheria are just a few 
omissions. Discussion of infections in burn patients or immu-
nosuppressed patients is omitted. Person-to-person nosocomial 
skin spread of dangerous, multiple-resistant bacteria is common 
and probably of great importance in hospitals today; discussion 
of this phenomenon has also been omitted. These are areas 
where research and patient care activities involve many spe-
cialty groups, including dermatology. 
1. HERPES SIMPLEX 
Prevalence And Severity 
Herpes simplex is a viral infection which is virtually ubiqui-
tous in the population. Serum antibodies indicating previous 
infection with herpes simplex are present in 70% of the entire 
American population and in 100% of people in lower socioeco-
nomic groups. 
The m'ost pressing current problem in herpes simplex infec-
tion is the rapid spread of herpetic genital disease. The inci-
dence of general herpes simplex disease is increasing in epidemic 
proportions. In only 5 years, it has risen from obscurity to the 
second most common venereal disease and it is now second 
only to gonorrhea. Herpes simplex venereal disease now is far 
more frequent than syphilis. 
Primary herpes simplex infection is a severe and extremely 
painful process that usually affects the mouth in children or 
the genitalia in young adults. The primary infection commonly 
lasts for 1 to 3 weeks. Severe cases require hospitalization for 
intravenous feeding (primary herpetic gingivostomatitis), for 
urinary bladder drainage (primary genital herpes), and for 
intensive topical therapy and pain relief. Recurrent herpetic 
infection of the lips (herpes labialis) is commonly known as cold 
sores or fever blisters. Severe episodes may be precipitated by 
sun exposure or by febrile illnesses. Recurrent lip infection may 
serve as a source of genital infection via orogenital sex. Herpetic 
infection of the genitalia (herpes genitaIis) is manifest initially 
as a severe primary infection and, subsequently, by recurrences 
of exquisitely sensitive and contagious recurrent focal lesions. 
Herpes genitalis is transmitted by sexual intercourse. Herpetic 
infection of the cervix (herpetic cervicitis) occurs concomitantly 
with herpes genitalis in the female. Seroepidemiological studies 
indicate that herpetic infection of the cervix is associated with 
cervical carcinoma. The increasing incidence of genital herpes 
gives rise to fears of increasing incidence of cervical carcinoma 
in the future. 
Herpetic infection of the newborn is fatal for a high percent-
age of affected babies. In those infants who survive the initial 
infection, neurologic damage and mental retardation are com-
mon. Infection of the eye (herpes keratitis) results in 18,000 
cases of blindness in the United States per year. Infection of 
the brain (herpes encephalitis) occurs in young to middle-aged 
adults. The disease results in death or severe neurological 
damage. In the elderly and the ill herpes may disseminate 
throughout the body, resulting in death. 
Prevention, Treatment and Cure 
There is no effective therapy for herpes simplex infection. As 
a consequence, herpes genitalis is an incurable venereal disease. 
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The sociological and emotional impact of this disease is enor_ 
mous and is increasing daily. Besides the fear that herpes 
simplex infection of the cervix may be a cause of cervical cancer, 
t.here is the proven concern that herpes simplex infection of the 
fetus and newborn transmitted from the cervix causes severe 
neurologic damage and mental retardation in a high percentage 
of infected infants. 
Since disseminated herpetic infections can have such serious 
consequences it is imperative that effective treatments and 
preventive measures be sought. 
Status of Research 
Animal studies with antiherpes vaccine are encouraging. Vac_ 
cines produced from the envelopes of herpes simplex vir\ls 
protect rabbits and guinea pigs against otherwise lethal dOSes 
of virus. 
One antiviral drug (adenine arabinoside) shows promise as a 
useful therapeutic agent in the treatment of herpes simplex 
infections in humans. Literally thousands of potential antiviral 
agents must be screened in order to fmd more effective thera_ 
peutic agents for specific devastating illnesses, such as herpes 
genitalis, herpes cervicitis, herpes keratitis, and herpes enceph. 
alitis, and for disseminated infection of the newborn, the ill, and 
the aged. 
Needs for Additional Research 
1. An effective antiherpes vaccine must be developed. Vac_ 
cines that work in rabbits and guinea pigs are now available. 
The technology for refining and purifying these crude vaccines 
for human use is at hand. 
2. There is no effective therapy for herpes simplex. There are 
potentiaUy effective antiviral drugs that have not been evalu. 
ated. Animal and in vitro testing techniques are established 
and protocols for human clinical studies are available. They 
should be put to use. 
3. The relationship of herpes simplex to cervical cancer must 
be investigated. Such studies will not only increase our under. 
standing of cervical cancer; the results may also extend to other 
human cancers, lymphomas, and l,eukemias that may be virally. 
induced. 
2. SEXUALLY TRANSMITTED INFECTIONS 
Prevalence and Severity 
Traditionally venereal disease has been the concern and 
responsibility of the dermatologist. Treatment is now fairly 
standardized; detection of the unsuspected case and sleuthing 
for contacts are not. It is here that public health ' facilities have 
assumed and must continue to assume responsibility. WheTI' 
these facilities are not immediately available, syphilis, lympho. 
granuloma venereum, and granuloma inguinale are routinely 
referred to dermatological services. So too are gonococcal, 
candidal, and herpetic infections if sexually transmitted. When 
the complaint is urethritis or vaginitis the patient may be 
triaged to urology or gynecology. Because cost data are avail· 
able for the detection and treatment of venereal disease, the 
price of these dermatological illnesses can be readily assessed. 
Syphilis. The third most frequently reported communicabl 
disease in the United States is syphilis; it is an endemic an 
potentially epidemic disease. In 1976,76,736 cases were report 
(Table 1) of which 24,933 cases were primary and secondRr) 
(the infectious stages), a considerable infection rate despite . 
decline in 3.2% from the preceding ye.ar. A total of 18,1 i/ 
infectious cases (72.7%) were recorded m men (72.7%); 6, I 
cases (27.3%) in women. A shift toward men in reports of earl~ 
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TABLE I. Cases of venereal disease reported by state health 
departments" United States total, 1976 
Disease Number of Cases Rate per 100.000 
Syphilis 
All Stages" 
Infectious 
Early latent 
Late & la te latent 
Congeni tal 
Gonorrhea 
Chancroid 
Granu loma inguinale 
Lymphogranuloma venereum 
76,736 
24,933 
26,225 
24,594 
764 
1,011 ,014 
583 
76 
332 
" K nown military cases excluded. 
" Includes "Stage of Syphilis Not Stated." 
,. Rates less than 0.05 are shown as 0.0. 
36.3 
11.8 
12.4 
11.6 
0.4 
478.1 
0.3 
0.0" 
0.2 
Source: VD Fact Sheet 1976, Ed ition 33, U.S. Department of HEW, 
Public Health Service, CDC, HEW Publication No. (CDC) 77-8195. 
syphilis was first observed in 1970. By 1976, there were 2.7 men 
reported for every female with primary or secondary syphilis. 
The reporting of infectious syphilis is most frequent from 
large cities in a distribution pattern similar to that of gonorrhea. 
In 1976,60.8% of reported cases derived from 27% of the ~atio~'s 
popuJation located in 63 cit ies, each with over 200,000 mhablt-
ants. The national primary and secondary syphilis case rate 
was 11.8 per 100,000 population. However, 4 cities repor.ted 
rates greater than 75.0 pel' 100,000: Charlo tte, North CarolIna, 
had 135.9' San Francisco California, 126.3; District of ColumbIa, 
90.4; and Atlanta, Georgia, 84.4 pel' 100,000. The wide variation 
in the rates of reported cases of infectious syphilis across the 
country may be due to differences in the search for su~h cases, 
to availabili ty of public health clinics and their reportm.g prac-
tices, to differences in actual attack rates, or to any combmatlOn 
of these. 
In 1975 the national case rates for primary and secondary 
syphilis i~dicated that young adul ts 20 to 24 years of age were 
at greatest risk for acquiring the disease with an attac~ rate of 
39.8 pel' 100,000 population. In descending order of rIsk were 
those 25 to 29 years of age, those 30 to 34 years of age, and last 
those 15 to 19 years of age. 
The number of reported cases was lower in 1976 than in the 
preceding year. For congeni tal syphilis there were 764 cases, a 
decline of25.4 % (Table lI) . Among infa nts less than one year of 
age, t here were 170 cases reported for a national case rate of 5.4 
per 100,000 live births, a decrease of 23. 1 % .01' 51 fewer cases. 
This decrease followed a pattern of a contmuous declme for 
four consecutive years. It has been suggested that serolOgIC 
testing of and follow-up programs for preg~ant women, as well 
as irrlproved prenatal care, were responslb.le. Ther: . was the 
same number of infant deaths due to congemtal syphilIS m 1976 
as in t he previous year. 
Latent syphilis shares in the decline. In 1976, 50,819 cases of 
latent syphilis were reported, of which 26,225 were early la~ent 
cases, (roughly the same number as reported for the prevIOus 
year), and 24,594 of which were late and l at~- latent cases (a 
decrease of 16.0% or 4,670 cases from the prevIOus year). Each 
of these cases was an infectious case that progressed undetected 
or with inadequate 0 1' untimely therapy a.nd serves to some 
degree to measure the effectiveness of publIc health measures. 
After correcting for underreporting and underdlagnosmg 
there was actually an estimated prevalence of 360,000 cases of 
untreated syphilis, most in the latent stage, for 1976. ~he actual 
incidence of new cases of infectious syphilis was estImated at 
79,000. 
Patients diagnosed and treated in the prima:y and secondary 
stage can achieve a clinical as well as a serologIC cure. ~owev~r, 
once a n individual gets into the late and latent stages or syphilIS, 
, there is a definite diminution of life expectancy. Furthermore, 
patients who develop lesions of late syph~i~ may. have perma-
nent destructive damage, such as syphilI t IC msamty or general 
paresis. 
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Although untreated syphilis need not eventuate in neuro-
syphilis, the cost for institutional care for patients ~ith sYP?i-
li tic psychoses approached $61 million for 1976 despIte a declIn-
ing case rate. Ten years ago, first admissions to hospitals for 
syphilitic psychoses numbered 154, a national case rate of 0.1 
pel' 100,000 population. 
Another of the tragedies of syphilis is the infection of the 
fetus in utero by a mother who has untreated syphilis. The 
result may be an a bortion, miscarriage, stillbirth, neonatal 
death, or a premature baby with congenital syphilis. . 
Deaths due to syphilis were reported at 272 in 1975, 200 m 
1976. T he underlying cause of death went unreported in count-
less instances, in deference to t he neurological and cardiovas-
cular defects wrought by the causative organism and the stigma 
of the diagnosis. 
Gonorrhea. The most freq uently reported communicable 
disease in the United States is gonorrhea. This disease is 
epidemic in the 15-30 year age group. T he total of 1,011,014 
reported cases for 1976 was an increase of 6.9% (65,069 cases) 
from the previous year. However, 2.7 million cases, or about 
one new infection every 12 seconds, are estimated to have 
actual ly occurred in 1976, an estimate reached by adjusting 
reported morbidity by a factor for the underreporting a nd 
underd iagnosing of cases. There were 602,135 cases of gonor-
rhea 60% of the total reported, that afflicted men, 72% more 
than' in 1975. T here were 408,879 cases, 40% of the total re-
ported, that afflicted women, 6.5% more than in 1975. 
T he national gonorrhea case rate in 1976 was 478 per 100,000 
population. Again, young adults from 20 to 24 years of age were 
at highest risk for acq uiring gonorrhea with a rate of 2128 per 
100,000 population. T hose from 15 to 19 years of age ranked 
second with a rate of 1292 per 100,000 population. As with 
syphilis, gonorrhea is most freq uently reported in large cities. 
S ixty-three cit ies, each with a population over 200,000 repre-
senti ng 27% of the populace, provided 53.3% of the reported 
cases. T he yearly cost of gonorrhea is estimated to be $773 
million. The cost in human suffering and disruption of family 
life is incalculable. 
Because pelvic inflammatory disease (PID) is a serious com-
plication of gonorrhea and a cause of female infertility,. it 
deserves special focus. Approximately 20% of those developmg 
PID require surgery, often including hysterectomy. Bacteremia, 
arthri tis, tendini t is, endocarditis, meningitis, and ophthalmIa 
neonatorum are potentially dangerous complications. PID oc-
curs in 17% of women with known gonorrhea; therefore an 
estimated 229,000 cases of PID existed in 1976. Scandinavian 
studies suggest that sterili ty develops in ~5-40% of wo~en 
following one episode of PID. If this holds III our popu.latl?n, 
34000 to 92,000 women underwent involuntary sterilIzatIOn o~ing to gonococcal pelvic inflammatory disease. Since partial 
tubu lar obstruction is among the sequellae, PID can cause 
ectopic pregnancies. More than 12% of deaths in pregnancy and 
childbirth were ascribed to PID. The cost of gonorrhea related 
PID for 1976 was $212 million, which covered the cost of 175,000 
hospital admissions, 1.2 million hospital days, and 105,000 
sw-gical procedures. In addition, 918,000 school days were lost 
that yeal' by young women owing to gonorrhea and its compli -
cations; that is, 5,750 girls were absent each school day because 
of PID. 
Other sexually tran.smitted diseases. Collection of data on a 
group of sexually transmitted diseases (STD)-nongonococcal 
TABLE II. Congenital Syphilis Reported Cases by Age in 1976 
Years Number of Cases Percent 
0-1 170 22.3 
1-4 16 2.1 
5-9 11 1.4 
10+ 567 74 .3 
All Ages 764 100.0 
Source: VD Fact Sheet 1976, Edition 33, U.S. Dept. of HEW Public 
Health Service, CDC. 
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urethritis, trichomoniasis, herpes simplex genital infection 
(Herpes Simplex Virus II or HSV II), scabies, pediculosis pubis, 
venereal warts and hepatitis B-is of moment because of their 
significant morbidity, even mortality in infants of infected 
mothers, and, in the case of herpes simplex, association with 
cancer. Although reporting is not required, incidence data have 
been estimated by the Venereal Disease Control Division of the 
CDC through use of the STD Surveillance System in venereal 
disease clinics across the country (Table III) and the data 
provided by t he National Disease and Therapeutic Index 
(NDTI). Calculations were made from the proportional fre-
quency of other STDs to the well-established estimated inci-
dence of gonorrhea (2,700,000) . 
The incidence of nongonococcal urethritis was approximately 
2,500,000 cases in 1976 (1,500,000 in men). According to the 
data from venereal disease clinics, its incidence is equal to or 
slightly greater than that of gonorrhea; according to the data 
from NDTI nongonococcal urethritis occurs half as often as 
gonorrhea in patients of physicians in private practice (Table 
IV). 
The incidence of HSV II differs widely among population 
TABLE III. Sexually Transmitted Diseases: Cases of S TDs among 
men and women per 100 male or female visits, respectively in STD 
Clinics 
Diagnosis Cases/ IOO male Cases/ 100 female 
visiL\) visils 
Gonorrhea 24.0 23.5 
Nongonoco~cal urethritis 24.8 
Trichomoniasis 11.5 
Candida 7.9 
Nonspecific vaginitis 12.2 
HSV II 3.4 2.1 
Venereal warts 4.3 4.0 
Syphilis 1.7 1.1 
Scabies 1.3 0.5 
Ped iculosis pubis 2.9 2.3 
Molluscum contagiosu m 1.0 0.3 
Chancroid 0.1 0.1 
Lymphogranuloma venereum 0.1 0.0 
Granuloma inguinale 0.0 0.0 
Total STD diagnoses 63.7 65.6 
Total Visits 23,798 11,264 
Source: "Nonreported Sexually Transmitted Diseases," Ronald K. 
St. John, M.D., et aI., Venereal Disease Contro l Division, Center for 
Disease Control. 
-
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groups. Although of relatively low incidence, it is a recurrent 
problem and its prevalence is increasing. In 1976 there were an 
estimated 200,000 to 300,000 cases. According to NDTI and 
STD Surveillance Surveys the number of cases of HSV II is 
13% of the number of cases of gonorrhea in patients attending 
venereal disease clinics and 11 % in patients consulting private 
physicians. In STD clinics there were 3.4 cases of herpes p er 
100 male visits and 2.1 cases of herpes per 100 female visits, an 
average of 3.0 cases per 100 visits. There were approximately 3 
t imes as many primary cases as there were recurrent ones 
Among men 76.5% of infections were primary, 23.5% recurrent: 
among women 78.4% were primary and 21.6% recurrent. ' 
Venereal warts (condyloma accuminata ) occur 18% as fre. 
quently as gonorrhea among VD clinic patients and 27% as 
frequently as gonorrhea among patients of private physicians. 
The estimated incidence in 1976 was 700,000, of which 300,000 
to 500,000 were new cases. 
Phthirus pubis or crab lice infestations were 12% as common 
as gonorrhea in VD clinics and 10% as common in private 
patients. Approximately 200,000 to 300,000 cases occurred in 
1976. Scabies, less common, had an estimated incidence of 
100,000 to 150,000 cases. 
Among women attending venereal disease clinics, trichoma. 
niasis is estimated to be half as common as gonorrhea, wherea 
among women in family planning clinics gonorrhea is rare and 
the incidence of t richomoniasis is high . In 1976, there were 
approximately 3,000,000 cases of trichomoniasis of which 1 to 
1.5 million were new. This figure may be an underestimation 
s ince women are frequently asymptomatic carriers of T. vagi. 
nale. 
Hepatitis B is a significant sexually transmitted disease 
especially among homosexual men. According to preliminar; 
data, the conversion rate of antigen positivity in selected homo. 
sexual populations can be as high as 10% per year, and according 
to prevalence data as many as 50% of male homosexuals may 
have the antibody, an indication of past infection. 
From these data, it appears that the sum of STDs other than 
gonorrhea and syphilis occur twice as often as gonorrhea. Al. 
though patients who attend venereal disease clinics are not a 
random sample of the population, prevalence data drawn from 
them give an idea of general prevalence. 
Cos/; of venereal disease control. The cost of venereal disease 
control was a bou t another $79.1 million in 1976. The federal 
government alone spent $31,102,402 in 1976 for this purpose, a 
figure that includes $9,327,366 for control of syphilis, $13,499,945 
for gonorrhea, and $8,275,091 for other activities (clinical ser. 
TABLE IV. Comparative Prevalence of Selected Sexually Transmitted Diseases 
Diagnosis 
Ma.les only 
Gonorrhea 
NGU 
All Cases 
Gonorrhea 
HSV II 
Venereal warts 
Pediculosis 
Pubis 
Trichomoniasis 
Scabies 
" Three primary cases: one recurrent case. 
Ratio of selected STDs to gonorrhea 
STD cl inics 
1.00 
1.1 3 
1.00 
0.13" 
0.18 
0.12 
0.50" 
FO.1 2 
Privat.e physicians'/ 
1.00 
0.56 ± 0.15 
1.00 
0.11 ± 0.07 
0.27 ± 0.13 
0.10 ±O.05 
Total estimated incidence 1976 
2,500,000 
(1,500,000 men) 
200,000-300,000 
700,000 
(300,000-500,000 new cases) 
200,000-300,000 
3,000,000" 
(1,000,000-1,500,000 new cases) 
100,000-1 50,000 
" In fam ily planning clinics, gonorrhea is rarely seen, but there is a high incidence of Trichomoniasis. 
,. Possible underestimate due to asymptomatic women carriers. 
" From NOT! data. 
Sources: "Nonreported Sexually Transmitted Diseases," Ronald K. St. John, M.D., Oscar G. Jones, B.S., and Beth Goldman, M.P.H., Venereal 
Disease Control Division, Center for Disease Control. 
Unpublished internal document, Beth Goldman,M.P.H. 1976, Venereal Disease Control Division, Center for Disease Control. 
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and surveillance programs). It is estimated that through these 
federal funds 3,790 cases of primary syphilis were averted at a 
cost of $2,461.00 per case and 169,322 cases of gonorrhea were 
avoided at $80.00 per case. 
Additional state and local government expenditures for con-
trol and treatment of gonorrhea and syphilis in 1976 amounted 
to $47,991,079. The funds were used for contact investigation 
and follow-up , for reactor follow-up, for screening, as well as for 
clinical services. Actually the clinical services comprise the 
largest proportion of state and local expenditures since federal 
grant funds may not be used for venereal disease treatment or 
for clinical facilities. N onfederal funding must be used to finance 
the rental and maintenance of health facilities, to pay profes-
sional personnel, and to purchase the supplies and equipment 
needed to examine, diagnose, and treat the patients. 
Prevention, Treatment, and Cure 
Syphilis can be treated. Penicillin is the drug of choice and 
patients who are allergic to penicillin may be treated with 
tetracycline or erythromycin, although there is controversy on 
how best to treat some of the complications of syphilis, such as 
central nervous system infection. 
Gonorrhea is poorly controlled for several reasons. Men as 
well as women may be infected and infectious, yet asympto-
matic. The diagnosis of gonorrhea in the female cannot be 
established without a positive culture, and cervical culture in 
women with gonorrhea yields about 30% false negatives. There 
is no way to prevent gonorrhea other than to promote the 
widespread use of antibiotics, which is not practicable. The 
emergence oflactamase (penicillinase)-producing, penicillin-re-
sistant gonococci (PPGC) has dramatically increased the prob-
lem of gonorrhea control. 
It appears that nongonococcal urethritis responds to tetra-
cycline therapy. However, with recent identification of some of 
the etiologic organisms, these studies must be repeated. The 
proper treatment of extra-genital complications of C trachom· 
atis infection still must be defined. 
Status of Research 
Syphilis. There have been studies of the metabolism and 
morphology of Treponema pallidum, the syphilis spirochete, 
yet microbiologists are frustrated in attempts to grow the 
organism in vitro. We also do not know why T . pallidum are 
virulent as compared to saprophytic treponemas although it 
has been observed that pathogenic spirochetes attach to tissue 
cells, which nonpathogenic ones fail to do. The immunology of 
syphilis, including the nature of immunity and the factors 
allowing reinfection, remain obscure. 
Two types of serological tests for syphilis have been devel-
oped: the nontreponemal and the specific treponemal tests. The 
family of nontreponemal tests (including the VDRL and 
RPRCT tests) depend on the presence of a nonspecific lipid-
containing antigen, reagin. These are sensitive screening tests 
that can be quantitated; unfortunately, false positive reactions 
are common. Thus, a positive reagin test must be confirmed by 
a test for specific antitreponemal antibody. The FT A-ABS test 
is commonly used. Although extremely sensitive and specific, 
this test has several limitations: it is expensive, subjective 
technically difficult to perform, time consuming, and not ame-
nable to automation. 
There is specific treatment for syphilis, but clinical facilities 
for diagnosis and treatment are inadequate. Moreover, there is 
still controversy regarding the proper treatment for neurosyph-
ilis. 
Gonorrhea. In the past decade, we have witnessed an im-
pressive increase in knowledge of the biology of Neisseria 
, gonorrhoeae. Some surface antigens, including pili antigens, 
have been purified, and there are investigators attempting to 
use them for serologic tests of gonorrhea . Different colonial 
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types have been recognized and related to the virulence of the 
organisms. The technic of autotyping to differentiate among 
strains of N. gonorrhoeae has been developed, thus facilitating 
epidemologic investigation. Transferrable R factors responsible 
for Beta lactamase synthesis have been identified. 
These advances, however, represent only a beginning of what 
we must know to control disease. Serologic tests are not yet 
adequate to diagnose gonorrhea in the acute phase, and the 
nature of gonococcal immunity is not yet understood. In chim-
panzees, resistance to urethral challenge can be achieved by 
immunization with that specific strain. It now appears that 
immunity is strain specific, as with the dozens of capsular types 
of penumococci. The putative antigen responsible for the strain 
specificity has not been identified. The factor(s) responsible for 
virulence is also elusive. 
It may not be possible to develop a good serologic test for 
acute gonorrhea because of multiple strains and persistence of 
antibody from previous infection. Diagnosis of gonorrhea in 
women still requires that a health professional obtain a speci-
men for culture, and it is clear that false negative cultures are 
common with this fragile organism. 
Nongonococcal urethritis (NGV). Two organisms responsi-
ble for this syndrome have now been identified: C. trachoma tis 
and Vreaplasma uT·ealyticum.. Other organisms are probably 
involved as well. The spectrum of disease caused by these 
etiologic agents is just beginning to be defined. 
Vaginitis is a clinically prominent disease, yet it is relatively 
neglected in research . Etiologic relationships cf the major or-
ganisms (trichomonas, Candida, Corynebacterium vaginale) in 
syndromes of vaginitis are not well defined. Some authorities 
feel that C. vaginale vaginitis is the most common sexually 
transmitted infection in women. The only currently effective 
therapy for trichomonas infections, the drug metronidazole, 
apparently has oncogenic potential, and restricted use has been 
strongly advised by the FDA. 
Needs for Additional Research 
Syphilis. Until the immunology of syphilis is unraveled, it is 
unlikely that the goal of syphilis immunization can be achieved. 
Therefore, studies should be directed at problems of growing T. 
pallidum in culture with the goal of better understanding the 
immunology of this disease. 
Tests for syphilis need improvement. Efforts should be placed 
on the development of a sensitive and specific treponemal test 
that, contrary to the fluorescent-treponema! absorption test, 
could be automated for inexpensive, reliable laboratory analy-
S IS. 
Further study of the disease, preferably in an international 
center which would have access to more patients would do 
much to resolve the controversy over treatment. 
Gonorrhea. The nature of gonococcal immunity, which now 
appears to be strain-specific, is not yet understood. We must 
continue studies on the biology of N . gononheae and the nature 
of immunity to this organism. Such understanding could very 
well lead to the development of specific serological tests to 
diagnose gonorrhea in the acute phase, and methods for im-
munizing against the disease. 
Since 3 million people are infected with gonorrhea each year 
in the United States and the disease is epidemic in the 15-30 
year age group it is mandatory' to develop a rapid technique 
whereby the organisms may be recognized directly without the 
need for culture. Epidemiological investigations of outbreaks of 
gonorrhea must be pursued aggressively if resistant organisms 
(such as the penicillin resistant strain) are to be contained. The 
goal is to find the most cost-effective methods to interrupt 
epidemics. Some effort should concentrate on developing forms 
of therapy that are least likely to promote the development of 
antibiotic resistant strains of gonorrhea. 
Nongonococcal urethritis. Nongonococcal urethritis may be 
more common than gonorrhea. So far, 2 organisms responsible 
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for this syndrome have been identified: Chlamydia trachomatis 
and Ureaplasma urealyticum. The extent .of disease caused by 
these etiologic agents is just beginning to be appreciated. Fur-
ther epidemiologic studies and studies to define proper therapy 
are in order. 
3. PYODERMAS 
Prevalence and Severity 
Bacterial skin infections (pyodermas) are common afflictions 
that can occur in any age, sex, or race. They are most common 
among disadvantaged populations in hot climates where over-
crowding and poor hygiene prevail. Children are at much 
greater risk; however, the war in Vietnam dramatically dem-
onstrated that healthy adults under adverse conditions are also 
susceptible. In emerging countries, the problem is one of major 
proportions. Up to 50% of aU "front-line" medical services in 
some tropical areas are tied down by skin infections. 
The annual incidence of infections approaches 100% in high 
risk populations (such as children of lmv income families in 
large cities and children on Indian Reservations). Point preva-
lence ranges from less than 1% in affluent neighborhoods to 
40% in high risk school children. There are virtually no available 
data on the prevalence or incidence in preschoolers, although 
the work on clinic populations suggests that these children are 
at even greater risk than their older siblings. 
Certainly the magnitude of the problem is greatly underes-
timated, partly because the population at greatest risk is the 
least likely to have standard medical care available, and partly 
because skin infections are dealt with in a variety of ways 
(family physician, emergency rooms, school nurses, etc.) . 
Self medication probably is a major treatment method, and 
the American public undoubtedly spends millions of dollars on 
remedies, many of which have been poorly evaluated by today's 
standards. 
By faJ" , the greatest proportion of cases in the population at 
large results from streptococcal infections of minor wounds, 
abrasions, and insect bites. Staphylococcus aureus usually co-
exists in the lesions. Furuncles, bullous impetigo, and the severe 
disease of childhood, "scalded skin syndrome," are caused by 
particular strains of S. aureus. 
Bullous impetigo is not confined to low income groups and 
may, in fact , be more common among affluent populations. 
Furuncles, which have been relatively rare in the last 10 years, 
appear to be returning and can become epidemic and recurrent 
among young people with frequent and intimate contacts. Dif-
ferent impressions are derived from clinic populations and 
physician practice. A dermatologist may well see mostly bullous 
impetigo, the emergency physicians encounter a higher propor-
tion of furuncles, and the community pediatrician may deal 
primarily with streptococcal pyoderma; thus, there is a real 
need for objective community surveys. 
Severity ranges from single minor infections such as an insect 
bite to multiple major infections resulting in painful and disfig-
uring ulcerations. The ·skin strains of streptococci contain a 
much larger number of nephritogenic types that can eventually 
produce acute glomerulonephritis (AGN) than do the throat 
strains. Introduction of nephritogenic strains into a high risk 
population can result in epidemics of AGN. 
Streptococcal cellulitis, itself a painful affliction often requir-
ing hospitalization, may leave the patient with permanent dam-
age to the lymphatic system. 
Furunculosis may be incapacitating or even life threatening, 
especially when occurring in the central area of the face. 
Bullous impetigo, although unsightly, is usually self limiting. 
It can be highly contagious. 
Staphylococcal scalded skin syndrome carries with it all the 
dangers of a large scale second degree burn or scald and can be 
fatal in young children. 
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Prevention, Treatment, and Cure 
Prevention of skin infections can, to some extent, be initiated 
by improvement in hygiene and living conditions. Currently 
available antibacterial soaps have not proven successful in 
preventing streptococcal pyoderma, and use of prophylactic 
systemic antibiotics has failed to produce any long-lasting bene-
fit to the population at risk. One recently completed study 
suggests a role for chlorhexidine gluconate as a topical agent 
with beneficial prophylactic effect; however, we are still a long 
way from achieving any worthwhile preventive programs. 
Although appropriate systemic antibiotic therapy is currently 
available, the everpresent threat of the emergence of strains of 
S. aureus resistant to today's antibiotics necessitates our con-
tinuing development and evaluation of new ones. 
Virtually all acute infections can be "cured," but the sequel-
lae, particularly of streptococcal infections, may create lifelong 
problems. Recurrent infections in individuals with impaired 
host defenses involve costly health care over many years and 
bring financial ruin to the patient. This problem deserves 
special emphasis. 
Status of Research 
Bacteria causing pyoderma. Streptococci and staphylococci 
are among the bacteria most intensively studied by microbiol-
ogists. As with most bacteria, however, the mechanisms or 
factors responsible for virulence are, at best, only partially 
understood. 
With group A streptococci, it has become clear that resistance 
is type specific, depending usually on the surface antigens eM: 
proteins) of the bacteria. Many extracellular enzymes and toxins 
have been studied some of which seem to be involved in the 
virulence of streptococci, such as hyaluronidase, and some of 
which cause specific manifestations of streptococcal disease, 
such as the erythrogenic factor in scarlet fever. No definitive 
statement explaining the extraordinary virulence of group A 
streptococci can yet be made. Some distinctive features of the 
pyoderma or "impetigo" streptococci have been delineated: 
serotypes, biochemical reactions and characteristics, and anti-
body responses. However, why these strains have a propensity 
to infect the skin and why some of these are nephritogenic is 
far from clear. 
Similarly, with staphylococci the virulence or aggressiveness 
of certain strains (e.g., Group II and phage type 71) has been 
noted but not fully explained. An exciting recent breakthrough 
has been the isolation and characterization of a toxin from 
phage group II staphylococci that is responsible for bullous 
impetigo and staphylococcal scalded skin syndrome. This toxin 
(exfoliatin) causes the epidermis to fall apart; when we under-
stand the mechanism of action of "exfoliatin" we shall likely be 
able to identify some important factors responsible for epider-
mal integrity. 
Host factors in pyodermas. The skin defenses against infec-
tion have been the subject of much study and speculation. Most 
authorities will agree that the major defense is the integrity of 
the epidermis. Clearly most pyoderma is engrafted on minor 
loss of integrity of the epidermis secondary to trauma or a 
disease, such as scabies. Most bacteria are killed by dessication 
occurring on the surface of normal skin. There is an increased 
incidence of skin infections in hot, humid environments where 
the stratum corneum is continually in a more hydrated state 
and barrier function is impaired. 
The flora of the skin has been extensively studied. In normal 
people, it is rather constant (especially anaerobic and aerobic 
diphtheroids and· s. epidermis), suggesting that this particular 
ecologic niche becomes populated by a rather limited number 
of organisms that have a selective advantage. These organisms 
are fortunately quite susceptible to host humoral and cellular 
defenses. Hence, they rarely cause infection even when epider-
mal injury occurs. Since these bacteria have a selective advan-
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tage over potentially more pathogenic bacteria, it is likely that 
this type of bacterial interference is an important evolutionary 
defense against infection. When the normal skin flora is de-
ranged by environmental abberations, by illness, by hospitali-
zation, or by the use of antibiotics or antiseptics, the skin flora 
is altered, and susceptibility to invasive bacterial infection is 
dramatically increased. Of course, when host humoral or cel-
lular defenses are overloaded, the person's risk of invasive skin 
infection is markedly increased. Although this is a relatively 
rare event, it is becoming more common with the increase in 
use of immunosuppressive and antimetabolic agents in therapy. 
Needs for Additional Research 
Research must be directed toward the basic virulence factors 
responsible for the invasiveness of streptococci and staphylo-
cocci. Specifically, we need to know if there are toxins or 
extracellular products as yet unidentified that are central to the 
infectivity of the organisms. Are some factors of major impor-
tance in pathogenesis already described but as yet unrecognized 
as pathogenic? Why do some Group 1 streptococci cause skin 
infections and others cause glomerulonephritis? 
Methods to pinpoint susceptible persons should be devel-
oped, perhaps by skin testing with "avirulent" organisms. Also 
we know that person-to-person contact spreads impetigo. Can 
this knowledge be used to interrupt the epidemic cycle of 
infection? 
Studies have shown that systemic antibiotics are effective in 
the treatment of impetigo and that topical antibiotics may not 
be. Millions of dollars per year are spent on topical antibiotics 
for use against impetigo. In view of this several steps should be 
taken. First, a major effort should be made to inform both 
physicians and the public that the use of topical antibiotics in 
established skin infections may be wasteful. Secondly, carefully 
designed studies should be initiated on the efficacy of topical 
antibiotics in the treatment of various skin infections. Finally, 
topical antibiotics may be very useful in preventing infections. 
The possibility of using topical antibiotics to reduce risk of skin 
infection in highly susceptible people should be investigated. 
Studies should be undertaken to determine what factors are 
responsible for susceptibility to boils and their recurrence. 
A method other than the time-consuming and relatively 
expensive technique of bacterial culture should be developed to 
diagnose impetigo. 
Studies are needed that follow over extended periods the 
complications of skin infections, particularly those arising from 
Group A streptococci such as chronic glomerulonephritis and 
hypertension. Do repeated infections bring about such compli-
cations? 
We also need to determine ecological factors in various re-
gions of the skin that appear to account for regional differences 
in susceptibility to ambient as well as resident bacterial growth. 
4. FUNGAL INFECTIONS 
Prevalence and Severity 
In a national survey conducted between 1971-74, dermato-
phytoses emerged as second only to acne as the most frequently 
occurring skin disease among Americans of all ages and sex. In 
men, it was by far the most common disease, with tinea pedis, 
(T. pedis) or "Athletes' Foot" accounting for almost two-thirds 
of all cases of fungal infections. 
In high risk groups, such as military recruits in the summer, 
the prevalence of T pedis is as high as 80%, and this figure has 
Dot changed significantly since the 1940s. 
In Vietnam in 1968 and among Colombian soldiers in 1976, 
severe tinea corporis affected 70% of operational troops. Cli-
mate, occupation, and the wearing of occlusive clothing and 
footwear significantly affect the prevalence and severity of 
fungal infections. Expected prevalence and severity can be 
rather accurately predicted from data already accumulated. 
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The severity of these diseases range from minor flaking of the 
feet to highly inflammatory wide-spread eruptions over large 
areas of the body in cases of ringworm infections. Candidiasis 
is implicated in diaper dermatitis, vaginitis. and severe skin 
eruptions. Diabetics are particular susceptible to the last. Der-
matophytes are emerging as significant invaders of the body's 
defenses. often with fatal results in debilitated patients, in those 
undergoing chemotherapy and immunosuppression, and in hy-
peralimentation. 
Effects on quality of life. Dermatophytosis in itself is not life-
threatening and is rarely totally disabling. The disfiguring 
rashes, loss of hair in children, unsightly nails. and the constant 
annoyance from the symptoms of athletes' foot clearly affects 
the quality of the life for several million Americans. The vast 
sums of money spent annually to relieve these symptoms indi-
cate great public concern. 
Candidiasis is characterized by intense pruritus. It is a sig-
nificant contributing factor to severe diaper dermatitis. It is a 
common cause of distressing vaginitis in women. All these 
conditions affect the quality of life. Serious opportunistic infec-
tions by C. albicans in debilitated patients poses an increasing 
till'eat to their survival. 
Estimates of the annual cost. These data are difficult to 
obtain. It is clear. however. that the cost is enormous. The 
volume of sales for topical antifungals is over $150 million per 
year, indicating the magnitude of the problem. We have even 
less accmate data on other costs: of lost patient working hours, 
of doctors visits. and of the magnitude of workmens compen-
sation claims. 
Prevention, Treatment, and Cure 
Most uncomplicated cases of superficial fungal infections can 
be successfully treated with available topical antifungals. Un-
fortunately. recurrence of the infection is the rule rather than 
the exception, particularly for T. pedis. There is no permanent 
"cme" for athletes foot. 
There is no successful topical therapy for fungal infections of 
the nails and scalp. and the only effective oral antibiotic, 
~'iseofulvin, is falling under increased suspicion as a possible 
teratogenic or carcinogenic agent. There is no safe and effective 
oral agent for candidiasis. although 5-fluorocytosine has been 
used in treating certain susceptible strains. 
There have been no adequately designed studies on the 
effectiveness of available topical agents. 
Status of Research 
There have been relatively few major advances in research 
on dermatophyte infections during the last 50 years. The dev-
astating effects of fungal infections on troop strength in Vietnam 
stimulated considerable work on epidemiology and environ-
mental influences. and there is a renewed interest in human 
models of infections and some new work on the immunology of 
dermatophytosis. 
Very recent studies have uncovered a possible mechanism for 
the adverse effects of occlusion on dermatophytosis that' is 
related to CO2 levels on the skin surface. However. we know 
little about the actual mechanisms of colonization and invasion 
or what toxic or allergenic products are produced by these 
fungi. Although it is clear that products produced by fungi 
penetrate the skin to produce the host reaction, these products 
have not been identified. 
Inhibition of production. blockage or neutralization of the 
fungal metabolites, and protection of the target organ are as 
yet unexplored therapeutic possibilities. 
Little is known about alleriic phenomena and immunologic 
mechanisms in fungal infections; in fact, we know little more 
now than we did in 1900 about why some patients quickly reject 
a fungal infection whereas others maintain a chronic state of 
disease. 
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Needs for Additional Research 
Fungitoxic agents may not be the only effective therapy. 
Identification and characterization of the toxic and allergenic 
products produced by fungi might very weD lead to entirely 
new approaches to t herapy or even to prevention of infection. 
The immunological aspects of fungal infections are not weD 
understood and should be studied. 
There is a need for a definitive, simple, and quick method for 
diagnosis of fungal infections. Presently, infections must be 
cultured, a process that takes 2 weeks and the services of a 
trained mycologist. 
Better therapeutic agents for fungal infections are needed: 
particularly, we need products with both antifungal and anti-
inflammatory activity. For instance, oral antifungal agents are 
needed for use in scalp and nail infections and recalcitrant cases 
of ringworm. Systemic therapeutic agents for candidiasis could 
be lifesaving to debilitated or immunosuppressed patients. Sus-
tained-release topical antifungal agents that could be inserted 
into shoes or incorporated into microencapsulation systems and 
would release agents onto the skin in response to sweating, 
might be quite effective. Also, a chemical method for reducing 
CO~ concentration under occlusive clothing should be studied. 
Independent studies should be sponsored on the usefulness 
of topical antifungal agents sold in such enormous quantities, a 
large share of which is over-the-counter products. 
5. INFEST A nONS 
Prevalence and Severity 
Scabies and pediculosis, the major problems of infestation in 
man, have been reported throughout history as causing much 
suffering and leading to major distressing economic as weD as 
medical consequences. In line with the current worldwide epi-
demic of scabies, it is most appropriate that this problem be 
reviewed and a course set for future work. 
Scabies, which were rare for over 20 years, is now pandemic. 
It has not been required to report scabies in the United States, 
and for this reason statistics are not available. According to the 
recent survey performed by members of the Parasitic Division 
of the Center for Disease Control, a bout 2-4% of patients seen 
in the dermatologists' offices have scabies. At the height of an 
epidemic this figure may be even higher. The socioeconomic 
characteristics of patients with scabies are representative of the 
overall population. Scabies may occur in anyone. 
Prevention, Treatment, and Cure 
The lesions of scabies have a characteristic distribution: 
commonly the hands, axillae, genitalia, and buttocks are af-
fected . The disease used to be characterized by burrows, the 
site of entrance and travel of the female sarcoptes through the 
epidermis. Burrows are infrequent in the current pandemic. 
There are also papules, excorciations, and nodules and the 
lesions can become secondarily infected. 
A number of special forms of scabies occur of which the most 
reported al'e in the ill, in the immunosuppressed, and in young 
children. Five to 10 percent of all Vietnamese children recently 
brought to the U.S. for adoption suffered from scabies. 
Status of Research 
Since scabies in the 1950s was a rare disease, many of the 
physicians who were training during that time or subsequently 
have little experience with the disease, and therefore are not 
making correct diagnoses. 
Much of the knowledge of the biology of Sarcoptes scabiei 
was obtained during a previous cycle (during World War II). In 
the present cycle there appears to be some differences. For 
example, the scarcity of burrows may be due to a predominance 
of immature forms of the organisms and a lesser number of 
mature females. This could account for the prominence of the 
"larval papules." 
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Scabies is frequently transmitted in sexually active young 
adults as a venereal disease, and frequently is combined with 
other venereal diseases. When a definite diagnosis of scabies is 
made, particularly in a sexually active young person in whom 
there are genital lesions, the patient should be scrutinized for 
other venereal disease. 
Scabies may turn out to be a classic immunologic disease 
Acute glomerulonephritis can develop in patients with scabie~ 
who have secondary infection with nephritogenic streptococcal 
strains. This is observed mainly in tropical climates, although 
it may occur wherever there are scabies. Patients, on immuno_ 
suppressive drugs who have recently undergone organ 
transplantation, might be more susceptible to infestation with 
crusted (Norwegian) scabies. 
Needs for Additional Research 
Sarcoptes scabiei could be grown in the laboratory by mod-
ifying techniques used with closely-related strains. Once this is 
done, it will be possible to identify those factors that are 
responsible for virulence, to develop a suitable animal model of 
human infestation, and to prepare appropriate antigens for 
immunologic studies of immediate and delayed hypersensitiv_ 
ity. 
Since scabies and pediculosis are man's major problems with 
infestation, we need to understand the biology of this organism. 
Much of the knowledge of the biology of Sarcoptes scabiei 
gained dUl'ing a previous epidemic (World War II) may not 
obtain for the current cycle. Obviously we should study the 
geographical distribution of the disease and its medical ento-
mology. The search for better forms of therapy for scabies 
should go on. Lindane, currently used in scabies therapy, may 
cause subclinical central nervous system damage. We shOuld 
look for the ideal therapeutic agent. It should kill the mite and 
egg rapidly. It should work in a single application. It should be 
as harmless to man as possible. It should not be a sensitizer. 
Known pesticides should be categorized and tested for their 
potency as ideal scabicides. Such ideal chemicals may exist, 
waiting to be identified as therapeutic agents. 
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